This protocol is judged by an institutional overview board, an independent team that testimonials any clinical trials involving individuals. If a research involves a Schedule I drug, when the board approves the protocol as moral, the scientists need to apply for an investigational new drug (IND) variety within the FDA.Medication could also comprise